Kimberly-Clark Strikes $40 Billion Deal for Tylenol Maker Kenvue

One of biggest takeovers so far this year will create a global company with annual revenues of roughly $32 billion.

Earnings live: Berkshire Hathaway profits rise as Buffett prepares to step down; Palantir results on deck

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

Earnings live: Berkshire Hathaway profits rise, Beyond Meat postpones earnings, with Palantir results on deck

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

Kenvue stock share price today: Kimberly-Clark to acquire Tylenol maker Kenvue for $40 billion in cash and stock deal. Here's background, current challenges, future out…

Kenvue stock share price today shows a major surge after Kimberly-Clark announced plans to buy Kenvue for over $40 billion.

Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.
Analytics Insight

Best DeFi Tools For Crypto Traders in 2025

Overview DeFi traders in 2025 rely on advanced DeFi tools for analytics, automation, and MEV protection in decentralized ...

/R E P E A T -- VVT Med Receives Order from Major US Healthcare Network NorthWell Health and Enters Into Investor Relations Agreements/

CNW/ - VVT Med Inc. (TSXV: VVTM) (the "Company" or "VVT Med"), a manufacturer of next-generation, minimally-invasive varicose vein treatments, is pleased ...

Asia Morning Briefing: Cautious Calm Returns to BTC Markets as Traders Rebuild Risk

BTC holds near $110K and Ethereum trades around $3,900 as liquidations ease and market makers report clients slowly ...

Buy, hold, sell: Amcor, ANZ, and Origin shares

What should you do with these blue chips? Let's see what one analyst is saying about them. The post Buy, hold, sell: Amcor, ...